Xi Cheng

2.8k total citations
108 papers, 2.0k citations indexed

About

Xi Cheng is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xi Cheng has authored 108 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 33 papers in Oncology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xi Cheng's work include Colorectal Cancer Surgical Treatments (10 papers), Epigenetics and DNA Methylation (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Xi Cheng is often cited by papers focused on Colorectal Cancer Surgical Treatments (10 papers), Epigenetics and DNA Methylation (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Xi Cheng collaborates with scholars based in China, United States and Italy. Xi Cheng's co-authors include Weihua Qiu, Haoran Feng, Ren Zhao, Zhijian Jin, Peter M. Pinsky, Yao Shen, Jie Kuang, Baiyong Shen, Juyong Liang and Wei Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Xi Cheng

102 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xi Cheng China	27	816	518	304	279	266	108	2.0k
Sang‐Yeob Kim South Korea	24	797 1.0×	440 0.8×	262 0.9×	271 1.0×	240 0.9×	81	1.6k
Qian Xie China	27	1.0k 1.3×	441 0.9×	412 1.4×	292 1.0×	238 0.9×	79	2.3k
Baocheng Wang China	29	867 1.1×	661 1.3×	336 1.1×	281 1.0×	343 1.3×	110	2.3k
Beihua Kong China	29	990 1.2×	523 1.0×	525 1.7×	409 1.5×	334 1.3×	99	2.3k
Yuan Chen China	27	1.2k 1.5×	516 1.0×	534 1.8×	310 1.1×	329 1.2×	121	2.4k
Norio Kubo Japan	23	568 0.7×	673 1.3×	314 1.0×	219 0.8×	260 1.0×	143	1.9k
Wenfeng Li China	26	957 1.2×	538 1.0×	651 2.1×	319 1.1×	380 1.4×	111	2.2k
Jingnan Wang China	28	1.1k 1.4×	605 1.2×	709 2.3×	383 1.4×	307 1.2×	128	2.6k
Jianquan Hou China	24	829 1.0×	364 0.7×	308 1.0×	382 1.4×	528 2.0×	93	2.3k

Countries citing papers authored by Xi Cheng

Since Specialization

Citations

This map shows the geographic impact of Xi Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Cheng more than expected).

Fields of papers citing papers by Xi Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Cheng. The network helps show where Xi Cheng may publish in the future.

Co-authorship network of co-authors of Xi Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Xi Cheng. A scholar is included among the top collaborators of Xi Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Cheng. Xi Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Zhuoqing, Wenqing Feng, Zifeng Xu, et al.. (2025). Agonist signaling drives neutrophil subpopulations to promote/inhibit colorectal cancer liver metastasis. Nature Communications. 17(1). 865–865.

Guo, Zichao, Haoran Feng, Wenqing Jia, et al.. (2025). Tertiary lymphoid structures signature predicts prognosis and clinical benefits from neoadjuvant chemotherapy and PD-1 blockade in colorectal adenocarcinoma. International Journal of Surgery. 111(8). 5088–5104. 1 indexed citations

Li, Chao, Zichao Guo, Wenqing Jia, et al.. (2025). Gold-Cerium bimetallic Star-Shaped nanoplatform for synergistic tumor therapy with nanozyme Catalytic/Photothermal/Chemotherapy. Journal of Colloid and Interface Science. 685. 753–765. 6 indexed citations

Xu, De‐Xiang, Xi Cheng, Chun‐Ying Huang, et al.. (2025). Recovery of rare earth elements from sediments affected by mining activities. Journal of Hazardous Materials. 496. 139223–139223. 1 indexed citations

Cheng, Xi, et al.. (2025). Centrality-Aware Collaborative Network Embedding for Overlapping Community Detection. IEEE Transactions on Network Science and Engineering. 13. 2236–2250.

Jiang, Rong, Yanling Feng, Xi Cheng, et al.. (2024). Surgery versus no surgery in platinum-sensitive relapsed ovarian cancer: final overall survival analysis of the SOC-1 randomized phase 3 trial. Nature Medicine. 30(8). 2181–2188. 14 indexed citations

Guo, Zichao, Yiqing Shi, Zijia Song, et al.. (2023). Single-incision robotic assisted surgery: a nonrandomized cohort pilot study on a novel surgical platform in colorectal surgery. International Journal of Surgery. 109(11). 3417–3429. 10 indexed citations

Liang, Jun, et al.. (2022). [Enhancing effects of chemical permeation enhancer propylene glycol and ultrasonic technology on transdermal permeation of Baimai Ointment].. PubMed. 47(24). 6607–6614. 1 indexed citations

Zhou, Tingting, et al.. (2022). Function and mechanism of histone β-hydroxybutyrylation in health and disease. Frontiers in Immunology. 13. 981285–981285. 54 indexed citations

10.

Shen, Xiaonan, Chunhua Zhou, Haoran Feng, et al.. (2022). ETV1 Positively Correlated With Immune Infiltration and Poor Clinical Prognosis in Colorectal Cancer. Frontiers in Immunology. 13. 939806–939806. 6 indexed citations

11.

Guo, Zichao, Xiaopin Ji, Shaodong Wang, et al.. (2022). Clinical Status and Future Prospects of Transanal Total Mesorectal Excision. Frontiers in Oncology. 11. 752737–752737. 6 indexed citations

12.

Liang, Juyong, Zhijian Jin, Jie Kuang, et al.. (2021). The role of anlotinib-mediated EGFR blockade in a positive feedback loop of CXCL11-EGF-EGFR signalling in anaplastic thyroid cancer angiogenesis. British Journal of Cancer. 125(3). 390–401. 28 indexed citations

13.

Feng, Haoran, Zhijian Jin, Juyong Liang, et al.. (2021). FOXK2 transcriptionally activating VEGFA induces apatinib resistance in anaplastic thyroid cancer through VEGFA/VEGFR1 pathway. Oncogene. 40(42). 6115–6129. 21 indexed citations

14.

Cheng, Xi, et al.. (2020). Neuroprotective effects of miR-532-5p against ischemic stroke. Metabolic Brain Disease. 35(5). 753–763. 23 indexed citations

15.

Lü, Xin, Eun‐Jung Jin, Xi Cheng, et al.. (2017). Opposing roles of TGFβ and BMP signaling in prostate cancer development. Genes & Development. 31(23-24). 2337–2342. 29 indexed citations

16.

Cheng, Xi, Huo Wu, Zhijian Jin, et al.. (2017). Up-regulation of chemokine receptor CCR4 is associated with Human Hepatocellular Carcinoma malignant behavior. Scientific Reports. 7(1). 12362–12362. 48 indexed citations

17.

Li, Ke, Baiyong Shen, Xi Cheng, et al.. (2016). Phenotypic and Signaling Consequences of a Novel Aberrantly Spliced Transcript FGF Receptor-3 in Hepatocellular Carcinoma. Cancer Research. 76(14). 4205–4215. 18 indexed citations

18.

Cheng, Xi, et al.. (2016). Numerical investigation of glucose transport and corneal metabolism in the anterior chamber in the presence of an iris-fixated intraocular lens. Investigative Ophthalmology & Visual Science. 57(12). 1–1. 5 indexed citations

19.

Cheng, Xi & Peter M. Pinsky. (2015). The Balance of Fluid and Osmotic Pressures across Active Biological Membranes with Application to the Corneal Endothelium. PLoS ONE. 10(12). e0145422–e0145422. 23 indexed citations

20.

Yang, Jiping, Huaijun Liu, Zhaolu Wang, et al.. (2009). The dose-effectiveness of intranasal VEGF in treatment of experimental stroke. Neuroscience Letters. 461(3). 212–216. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact